Suppr超能文献

比较接受与未接受慢性透析治疗的急性冠状动脉综合征患者(来自全球急性冠状动脉事件登记处[GRACE]登记处)。

Comparison of acute coronary syndrome in patients receiving versus not receiving chronic dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry).

机构信息

University of Michigan, Ann Arbor, USA.

出版信息

Am J Cardiol. 2012 Jan 1;109(1):19-25. doi: 10.1016/j.amjcard.2011.07.062. Epub 2011 Oct 4.

Abstract

Patients with end-stage renal disease commonly develop acute coronary syndromes (ACS). Little is known about the natural history of ACS in patients receiving dialysis. We evaluated the presentation, management, and outcomes of patients with ACS who were receiving dialysis before presentation for an ACS and were enrolled in the Global Registry of Acute Coronary Events (GRACE) at 123 hospitals in 14 countries from 1999 to 2007. Of 55,189 patients, 579 were required dialysis at presentation. Non-ST-segment elevation myocardial infarction was the most common ACS presentation in patients receiving dialysis, occurring in 50% (290 of 579) of patients versus 33% (17,955 of 54,610) of those not receiving dialysis. Patients receiving dialysis had greater in-hospital mortality rates (12% vs 4.8%; p <0.0001) and, among those who survived to discharge, greater 6-month mortality rates (13% vs 4.2%; p <0.0001), recurrent myocardial infarction (7.6% vs 2.9%; p <0.0001), and unplanned rehospitalization (31% vs 18%; p <0.0001). The outcome in patients receiving dialysis was worse than that predicted by their calculated GRACE risk score for in-hospital mortality (7.8% predicted vs 12% observed; p <0.05), 6-month mortality/myocardial infarction (10% predicted vs 21% observed; p <0.05). In conclusion, in the present large multinational study, approximately 1% of patients with ACS were receiving dialysis. They were more likely to present with non-ST-segment elevation myocardial infarction, and had markedly greater in-hospital and 6-month mortality. The GRACE risk score underestimated the risk of major events in patients receiving dialysis.

摘要

患有终末期肾病的患者通常会发生急性冠状动脉综合征(ACS)。在接受透析治疗的患者中,ACS 的自然病史知之甚少。我们评估了在发生 ACS 之前正在接受透析治疗且于 1999 年至 2007 年在 14 个国家的 123 家医院参加全球急性冠状动脉事件注册(GRACE)的患者中 ACS 的表现、处理和结局。在 55189 例患者中,有 579 例在就诊时需要透析。在接受透析治疗的患者中,最常见的 ACS 表现是非 ST 段抬高型心肌梗死,占 50%(290/579),而非接受透析治疗的患者为 33%(17955/54610)。接受透析治疗的患者院内死亡率更高(12%比 4.8%;p<0.0001),并且在存活至出院的患者中,6 个月死亡率更高(13%比 4.2%;p<0.0001)、复发性心肌梗死(7.6%比 2.9%;p<0.0001)和计划外再住院率(31%比 18%;p<0.0001)更高。接受透析治疗的患者的结局比其 GRACE 风险评分预测的院内死亡率(7.8%预测值比 12%观察值;p<0.05)、6 个月死亡率/心肌梗死(10%预测值比 21%观察值;p<0.05)更差。总之,在本项大型跨国研究中,约有 1%的 ACS 患者正在接受透析治疗。他们更有可能出现非 ST 段抬高型心肌梗死,且院内和 6 个月死亡率明显更高。GRACE 风险评分低估了接受透析治疗的患者发生重大事件的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验